Security
Establishment Labs Holdings Inc. Common Shares · ESTA
ESTANASDAQCommon stockCurrentCIK 1688757Updated Oct 30, 2026
ESTA price & chart
Loading TradingView…
NASDAQ:ESTA on TradingView ↗About the company
Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women’s health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 100 countries. With five million Motiva® devices delivered to plastic and reconstructive surgeons since 2010, the company’s products have created a new standard for safety and patient satisfaction. The company’s minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for primary breast augmentation and primary mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zenso…
In the news
No coverage from other publishers is available.
Seeking Alpha
Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript ↗
Establishment Labs a new Buy at Stifel on end-market prospects ↗
SEC disclosures
ESTABLISHMENT LABS HOLDINGS INC. files 8-K: Material Event ↗
Recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
4 filing
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 338,895,000Source | 282,685,000Source | 351,926,000Source | 329,668,000Source | 285,088,000Source | 351,037,000Source | 333,364,000Source | 301,838,000Source | 357,167,000Source | 346,831,000Source | 268,641,000Source | 211,061,000Source |
| Property, Plant and Equipment, NetUSD | 76,241,000Source | 79,423,000Source | 73,998,000Source | 76,362,000Source | 79,546,000Source | 74,654,000Source | 76,390,000Source | 79,244,000Source | 75,615,000Source | 78,028,000Source | 77,205,000Source | 51,092,000Source |
| GoodwillUSD | 1,209,000Source | 465,000Source | 1,209,000Source | 1,209,000Source | 465,000Source | 1,209,000Source | 1,209,000Source | 465,000Source | 1,209,000Source | 1,209,000Source | 465,000Source | 465,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 10,399,000Source | 9,783,000Source | 9,430,000Source | 11,186,000Source | 10,041,000Source | 9,303,000Source | 11,566,000Source | 9,515,000Source | 9,942,000Source | 11,683,000Source | 7,987,000Source | 4,608,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 70,624,000Source | — | 71,157,000Source | 54,639,000Source | — | 68,101,000Source | 69,178,000Source | — | 75,572,000Source | 90,347,000Source | 40,035,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 71,442,000Source | 67,251,000Source | 75,650,000Source | 70,092,000Source | 59,982,000Source | 77,076,000Source | 63,236,000Source | 50,838,000Source | 77,497,000Source | 65,002,000Source | 46,918,000Source | 35,423,000Source |
| Inventory, NetUSD | 88,158,000Source | 67,122,000Source | 84,983,000Source | 94,683,000Source | 64,213,000Source | 86,659,000Source | 90,425,000Source | 72,489,000Source | 85,611,000Source | 78,766,000Source | 79,471,000Source | 36,583,000Source |
| Assets, CurrentUSD | 239,597,000Source | 182,953,000Source | 247,730,000Source | 229,168,000Source | 186,132,000Source | 245,827,000Source | 231,696,000Source | 203,695,000Source | 249,940,000Source | 243,037,000Source | 174,901,000Source | 149,904,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 9,373,000Source | 8,883,000Source | 15,940,000Source | 9,754,000Source | 7,337,000Source | 13,991,000Source | 8,857,000Source | 7,388,000Source | 11,260,000Source | 8,922,000Source | 8,477,000Source | 11,543,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,507,000Source | 4,849,000Source | 3,508,000Source | 4,802,000Source | 3,717,000Source | 3,930,000Source | 5,192,000Source | 3,908,000Source | 4,339,000Source | 5,561,000Source | 3,381,000Source | 3,702,000Source |
| Other Assets, NoncurrentUSD | 6,942,000Source | 5,212,000Source | 16,051,000Source | 6,941,000Source | 5,187,000Source | 16,114,000Source | 7,311,000Source | 5,011,000Source | 16,122,000Source | 7,313,000Source | 4,702,000Source | 1,290,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 322,532,000Source | 249,975,000Source | 330,319,000Source | 306,905,000Source | 240,069,000Source | 336,254,000Source | 294,814,000Source | 244,927,000Source | 333,620,000Source | 293,736,000Source | 250,246,000Source | 219,246,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 426,067,000Source | 368,930,000Source | 450,587,000Source | 425,855,000Source | 368,232,000Source | 434,529,000Source | 424,532,000Source | 367,138,000Source | 433,378,000Source | 420,364,000Source | 315,634,000Source | 223,637,000Source |
| Additional Paid in CapitalUSD | 84,864,000Source | 73,569,000Source | 92,603,000Source | 82,130,000Source | 70,004,000Source | 89,879,000Source | 79,117,000Source | 66,841,000Source | 87,624,000Source | 76,992,000Source | 63,748,000Source | 49,911,000Source |
| Retained Earnings (Accumulated Deficit)USD | -493,141,000Source | -410,161,000Source | -520,886,000Source | -481,995,000Source | -393,479,000Source | -509,138,000Source | -465,402,000Source | -376,298,000Source | -495,756,000Source | -444,692,000Source | -360,096,000Source | -281,594,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,427,000Source | 3,226,000Source | 2,157,000Source | -373,000Source | 3,116,000Source | 2,367,000Source | 3,157,000Source | 2,084,000Source | 1,155,000Source | 3,285,000Source | 1,963,000Source | 2,715,000Source |
| Stockholders' Equity Attributable to ParentUSD | 16,363,000Source | 32,710,000Source | 21,607,000Source | 22,763,000Source | 45,019,000Source | 14,783,000Source | 38,550,000Source | 56,911,000Source | 23,547,000Source | 53,095,000Source | 18,395,000Source | -8,185,000Source |
| Liabilities and EquityUSD | 338,895,000Source | 282,685,000Source | 351,926,000Source | 329,668,000Source | 285,088,000Source | 351,037,000Source | 333,364,000Source | 301,838,000Source | 357,167,000Source | 346,831,000Source | 268,641,000Source | 211,061,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 71,981,000Source | 50,498,000Source | 64,558,000Source | 80,742,000Source | 41,892,000Source | 83,153,000Source | 69,038,000Source | 48,016,000Source | 82,142,000Source | 68,278,000Source | 57,150,000Source | 38,959,000Source |
| Operating Lease, Liability, CurrentUSD | 1,721,000Source | 1,148,000Source | — | 1,618,000Source | 842,000Source | 1,715,000Source | 1,558,000Source | 837,000Source | 1,712,000Source | 1,514,000Source | 773,000Source | 688,000Source |
| Accounts Payable, CurrentUSD | 39,719,000Source | 34,397,000Source | 32,841,000Source | 55,806,000Source | 28,420,000Source | 41,813,000Source | 45,188,000Source | 31,070,000Source | 43,109,000Source | 44,760,000Source | 41,624,000Source | 20,034,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,982,000Source | 3,825,000Source | 1,972,000Source | 3,364,000Source | 2,989,000Source | 2,407,000Source | 3,803,000Source | 3,180,000Source | 2,820,000Source | 4,203,000Source | 2,712,000Source | 3,200,000Source |
| Other Liabilities, NoncurrentUSD | 1,111,000Source | 1,292,000Source | 2,087,000Source | 1,666,000Source | 1,456,000Source | 2,102,000Source | 1,633,000Source | 1,545,000Source | 1,136,000Source | 1,678,000Source | 1,645,000Source | 1,626,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 18,107,000Source | 13,821,000Source | 17,344,000Source | 17,367,000Source | 11,812,000Source | 22,211,000Source | 20,604,000Source | 15,207,000Source | 18,856,000Source | 16,536,000Source | 13,690,000Source | 17,237,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 246,458,000Source | 194,360,000Source | 261,702,000Source | 221,133,000Source | 193,732,000Source | 248,592,000Source | 220,340,000Source | 192,186,000Source | 247,522,000Source | 219,577,000Source | 188,739,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 1,500,000Source | 1,300,000Source | — | 1,600,000Source | 1,600,000Source | 1,600,000Source | 6,200,000Source | 4,700,000Source | 2,800,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,003,000Source | 2,434,000Source | 11,415,000Source | 14,404,000Source | 14,362,000Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -302,000Source | -775,000Source | 11,469,000Source | 26,278,000Source | 11,557,000Source | 12,333,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 624,000Source | 10,182,000Source | 7,060,000Source | 471,000Source | 42,230,000Source | 10,900,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -2,580,000Source | 1,354,000Source | -2,296,000Source | 6,671,000Source | 18,957,000Source | 4,376,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -9,435,000Source | -2,178,000Source | -3,706,000Source | 86,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -4,310,000Source | -20,725,000Source | -50,890,000Source | -58,516,000Source | -88,513,000Source | -52,166,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 0Source | 307,000Source | 307,000Source | 50,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,960,000Source | -1,336,000Source | -7,028,000Source | -15,611,000Source | -24,547,000Source | -34,791,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,853,000Source | 753,000Source | 6,049,000Source | 6,114,000Source | 7,908,000Source | 2,851,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 702,000Source | 282,000Source | 637,000Source | 510,000Source | 484,000Source | 4,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -864,000Source | -203,000Source | 40,434,000Source | 125,895,000Source | 86,227,000Source | 100,255,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -7,471,000Source | -21,169,000Source | -14,775,000Source | 50,312,000Source | -26,320,000Source | 12,940,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 70,624,000Source | 39,697,000Source | 71,157,000Source | 54,639,000Source | 68,101,000Source | 69,178,000Source | 75,572,000Source | 90,347,000Source | 40,035,000Source | 66,355,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 5,857,000Source | 5,142,000Source | 20,539,000Source | 9,806,000Source | 5,689,000Source | 5,363,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 1,042,000Source | 79,000Source | 420,000Source | 1,735,000Source | 2,165,000Source | 2,125,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -337,000Source | 1,095,000Source | 2,709,000Source | -1,456,000Source | 513,000Source | -358,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 2,894,000Source | 3,656,000Source | — | 3,185,000Source | 3,003,000Source | 2,434,000Source | 11,415,000Source | 14,404,000Source | 14,362,000Source | 13,358,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 1,070,000Source | 763,000Source | 3,445,000Source | 6,371,000Source | 13,278,000Source | 8,124,000Source |
| Amortization of Intangible AssetsUSD | — | — | 900,000Source | 600,000Source | — | 800,000Source | 800,000Source | 800,000Source | 3,300,000Source | 2,100,000Source | 1,200,000Source | 1,200,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -400,000Source | 2,200,000Source | — | 5,000,000Source | -300,000Source | 2,800,000Source | 6,400,000Source | -8,800,000Source | 1,800,000Source | -3,000,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | — | — | — | 428,000Source | 3,510,000Source | 9,956,000Source | -5,302,000Source | 4,181,000Source | -1,732,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 703,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -47,000Source | -436,000Source | -153,000Source | -163,000Source | -280,000Source | -229,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -19,019,000Source |
| GoodwillUSD | — | — | 1,209,000Source | 465,000Source | 1,209,000Source | 1,209,000Source | 1,209,000Source | 1,209,000Source | 1,209,000Source | 1,209,000Source | 465,000Source | 465,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 424,000Source | 510,000Source | 6,000Source | 1,004,000Source | 288,000Source | 914,000Source | -6,958,000Source | -32,000Source | -81,000Source | 2,385,000Source |
| InterestExpenseNonoperatingUSD | — | — | 6,203,000Source | 5,313,000Source | 7,034,000Source | 5,956,000Source | 7,088,000Source | 5,853,000Source | 25,256,000Source | 20,829,000Source | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 1,300,000Source | 650,000Source | 2,646,000Source | 1,805,000Source | 1,392,000Source | 1,577,000Source |
| Investment Income, InterestUSD | — | — | 48,000Source | 234,000Source | 36,000Source | 91,000Source | 26,000Source | 250,000Source | 423,000Source | 1,477,000Source | 1,020,000Source | 87,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -11,146,000Source | -16,682,000Source | -11,748,000Source | -16,593,000Source | -13,382,000Source | -20,710,000Source | -51,064,000Source | -84,596,000Source | -78,502,000Source | -75,209,000Source |
| Operating ExpensesUSD | — | — | 41,721,000Source | 38,856,000Source | 52,001,000Source | 49,379,000Source | 48,846,000Source | 44,754,000Source | 185,316,000Source | 159,512,000Source | 172,003,000Source | 146,253,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -542,000Source | 2,046,000Source | -454,000Source | 4,383,000Source | 479,000Source | 2,753,000Source | 5,819,000Source | -15,289,000Source | 816,000Source | -3,177,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 0Source | 0Source | 99,484,000Source | 84,538,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 1,008,000Source | 79,000Source | 7,589,000Source | 2,454,000Source | 2,173,000Source | 3,873,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 703,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 53,782,000Source | 40,227,000Source | 67,542,000Source | 51,300,000Source | 59,877,000Source | 41,377,000Source | 211,076,000Source | 166,025,000Source | 165,151,000Source | 161,700,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 37,166,000Source | 34,055,000Source | 46,905,000Source | 44,176,000Source | 43,605,000Source | 39,699,000Source | 165,069,000Source | 139,806,000Source | 145,575,000Source | 125,984,000Source |
| Operating Income (Loss)USD | — | — | -4,025,000Source | -13,139,000Source | -4,290,000Source | -14,107,000Source | -6,511,000Source | -16,946,000Source | -39,008,000Source | -49,987,000Source | -65,026,000Source | -39,658,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -542,000Source | 2,046,000Source | -454,000Source | 4,383,000Source | 479,000Source | 2,753,000Source | 5,819,000Source | -15,289,000Source | 816,000Source | -3,177,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -10,722,000Source | -16,172,000Source | -11,742,000Source | -15,589,000Source | -13,094,000Source | -19,796,000Source | -58,022,000Source | -84,628,000Source | -78,583,000Source | -72,824,000Source |
| Income Tax Expense (Benefit)USD | — | — | 424,000Source | 510,000Source | 6,000Source | 1,004,000Source | 288,000Source | 914,000Source | -6,958,000Source | -32,000Source | -81,000Source | 2,385,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -11,146,000Source | -16,682,000Source | -11,748,000Source | -16,593,000Source | -13,382,000Source | -20,710,000Source | -51,064,000Source | -84,596,000Source | -78,502,000Source | -75,209,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.38Source | -0.59Source | -0.39Source | -0.57Source | -0.45Source | -0.7Source | -1.72Source | -3Source | -3.07Source | -3.08Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.38Source | -0.59Source | -0.39Source | -0.57Source | -0.45Source | -0.7Source | -1.72Source | -3Source | -3.07Source | -3.08Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 29,622,101Source | 28,248,256Source | 30,121,685Source | 28,913,811Source | 29,947,157Source | 29,475,649Source | 29,620,022Source | 28,161,761Source | 25,600,029Source | 24,457,793Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 29,622,101Source | 28,248,256Source | 30,121,685Source | 28,913,811Source | 29,947,157Source | 29,475,649Source | 29,620,022Source | 28,161,761Source | 25,600,029Source | 24,457,793Source |
| Interest Expense (non-operating)USD | — | — | 6,203,000Source | 5,313,000Source | 7,034,000Source | 5,956,000Source | 7,088,000Source | 5,853,000Source | 25,256,000Source | 20,829,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 900,000Source | 600,000Source | — | 800,000Source | 800,000Source | 800,000Source | 3,300,000Source | 2,100,000Source | 1,200,000Source | 1,200,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 2,477,000Source | 2,146,000Source | 3,625,000Source | 2,299,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -400,000Source | 2,200,000Source | — | 5,000,000Source | -300,000Source | 2,800,000Source | 6,400,000Source | -8,800,000Source | 1,800,000Source | -3,000,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 703,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 37,696,000Source | 25,717,000Source | 47,711,000Source | 35,272,000Source | 42,335,000Source | 27,808,000Source | 146,308,000Source | 109,525,000Source | 106,977,000Source | 106,595,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -24,542,000Source | -60,665,000Source | -13,556,000Source | -9,721,000Source |
| Interest ExpenseUSD | — | — | — | 5,313,000Source | — | — | — | — | — | — | 15,393,000Source | 11,760,000Source |
| Investment Income, InterestUSD | — | — | 48,000Source | 234,000Source | 36,000Source | 91,000Source | 26,000Source | 250,000Source | 423,000Source | 1,477,000Source | 1,020,000Source | 87,000Source |
| Operating ExpensesUSD | — | — | 41,721,000Source | 38,856,000Source | 52,001,000Source | 49,379,000Source | 48,846,000Source | 44,754,000Source | 185,316,000Source | 159,512,000Source | 172,003,000Source | 146,253,000Source |
| Research and Development ExpenseUSD | — | — | 4,555,000Source | 4,801,000Source | 5,096,000Source | 5,203,000Source | 5,241,000Source | 5,055,000Source | 20,247,000Source | 19,706,000Source | 26,428,000Source | 20,269,000Source |
Filing attachments
estaerq32026-ex991.htm · 8-K · 2026-10-29
EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Malavika William mwilliam@establishmentlabs.com Establishment Labs® Reports Third Quarter 2026 Financial Results Revenue Increases 33.9% to $72.0 Million, Driven by 119% U.S. Growth Achieves First Quarter of Positive Operating and Free Cash Flow and Raises Full-Year Revenue Guidance NEW YORK, NY, October 29, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology …
Read attachment ↗estaerq22026-ex991.htm · 8-K · 2026-08-06
EX-99.1 2 estaerq22026-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Malavika William mwilliam@establishmentlabs.com Establishment Labs® Reports Second Quarter 2026 Financial Results NEW YORK, NY, August 6, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, toda…
Read attachment ↗estaerq12026-ex991.htm · 8-K · 2026-05-06
EX-99.1 2 estaerq12026-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Malavika William mwilliam@establishmentlabs.com Establishment Labs Reports First Quarter 2026 Financial Results NEW YORK, NY, May 6, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today ann…
Read attachment ↗a_esta8kerq425-ex991.htm · 8-K · 2026-02-24
EX-99.1 2 a_esta8kerq425-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Raj Denhoy 415 828-1044 rdenhoy@establishmentlabs.com Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance NEW YORK, NY, February 24, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health…
Read attachment ↗estaprq22025-ex991.htm · 8-K · 2025-08-07
EX-99.1 2 estaprq22025-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Raj Denhoy 415 828-1044 rdenhoy@establishmentlabs.com Establishment Labs Reports Second Quarter 2025 Financial Results NEW YORK, NY, August 7, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetic…
Read attachment ↗estaprq12025-ex991.htm · 8-K · 2025-05-07
EX-99.1 2 estaprq12025-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Raj Denhoy 415 828-1044 rdenhoy@establishmentlabs.com Establishment Labs Reports First Quarter 2025 Financial Results NEW YORK, NY, May 7, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics an…
Read attachment ↗